These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 24497314)

  • 21. A Small-scale Model to Assess the Risk of Leachables from Single-use Bioprocess Containers through Protein Quality Characterization.
    Xiao NJ; Medley CD; Shieh IC; Downing G; Pizarro S; Liu J; Patel AR
    PDA J Pharm Sci Technol; 2016 11/12; 70(6):533-546. PubMed ID: 27325598
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Automated disposable small scale reactor for high throughput bioprocess development: a proof of concept study.
    Bareither R; Bargh N; Oakeshott R; Watts K; Pollard D
    Biotechnol Bioeng; 2013 Dec; 110(12):3126-38. PubMed ID: 23775295
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fully Disposable Manufacturing Concepts for Clinical and Commercial Manufacturing and Ballroom Concepts.
    Boedeker B; Goldstein A; Mahajan E
    Adv Biochem Eng Biotechnol; 2018; 165():179-210. PubMed ID: 29101419
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Application of a cell-once-through perfusion strategy for production of recombinant antibody from rCHO cells in a Centritech Lab II centrifuge system.
    Kim BJ; Chang HN; Oh DJ
    Biotechnol Prog; 2007; 23(5):1186-97. PubMed ID: 17691812
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Use of disposable reactors to generate inoculum cultures for E. coli production fermentations.
    Mahajan E; Matthews T; Hamilton R; Laird MW
    Biotechnol Prog; 2010; 26(4):1200-3. PubMed ID: 20730774
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hybrid and disposable facilities for manufacturing of biopharmaceuticals: pros and cons.
    Ravisé A; Cameau E; De Abreu G; Pralong A
    Adv Biochem Eng Biotechnol; 2009; 115():185-219. PubMed ID: 19623478
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Integrated continuous production of recombinant therapeutic proteins.
    Warikoo V; Godawat R; Brower K; Jain S; Cummings D; Simons E; Johnson T; Walther J; Yu M; Wright B; McLarty J; Karey KP; Hwang C; Zhou W; Riske F; Konstantinov K
    Biotechnol Bioeng; 2012 Dec; 109(12):3018-29. PubMed ID: 22729761
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Disposables in downstream processing.
    Gottschalk U
    Adv Biochem Eng Biotechnol; 2009; 115():171-83. PubMed ID: 19373450
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Performance of high intensity fed-batch mammalian cell cultures in disposable bioreactor systems.
    Smelko JP; Wiltberger KR; Hickman EF; Morris BJ; Blackburn TJ; Ryll T
    Biotechnol Prog; 2011; 27(5):1358-64. PubMed ID: 21626722
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of solvent systems for optimized extractables studies of single use bioprocessing solutions.
    Dorival-García N; Bones J
    J Chromatogr A; 2017 Sep; 1513():69-77. PubMed ID: 28739275
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Microbioreactors and scale-down models: growth of CHO cells using the Pall Micro24 MicroReactor system.
    Warr SR
    Methods Mol Biol; 2014; 1104():149-65. PubMed ID: 24297415
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biosorption of process-equipment-related leachables (PERLs) in biomanufacturing: A quantitative approach to study partitioning of PERLs in a cell culture system.
    Bossong M; Budde D; Hauk A; Pahl I; Menzel R; Langguth P
    Int J Pharm; 2023 Mar; 635():122742. PubMed ID: 36804518
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Production of a secreted glycoprotein from an inducible promoter system in a perfusion bioreactor.
    Lipscomb ML; Mowry MC; Kompala DS
    Biotechnol Prog; 2004; 20(5):1402-7. PubMed ID: 15458323
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A systematic approach for scale-down model development and characterization of commercial cell culture processes.
    Li F; Hashimura Y; Pendleton R; Harms J; Collins E; Lee B
    Biotechnol Prog; 2006; 22(3):696-703. PubMed ID: 16739951
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multivariate analysis of cell culture bioprocess data--lactate consumption as process indicator.
    Le H; Kabbur S; Pollastrini L; Sun Z; Mills K; Johnson K; Karypis G; Hu WS
    J Biotechnol; 2012 Dec; 162(2-3):210-23. PubMed ID: 22974585
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Disposable bioreactors for plant micropropagation and mass plant cell culture.
    Ducos JP; Terrier B; Courtois D
    Adv Biochem Eng Biotechnol; 2009; 115():89-115. PubMed ID: 19475375
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Metabolic analysis of antibody producing CHO cells in fed-batch production.
    Dean J; Reddy P
    Biotechnol Bioeng; 2013 Jun; 110(6):1735-47. PubMed ID: 23296898
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Single-use disposable technologies for biopharmaceutical manufacturing.
    Shukla AA; Gottschalk U
    Trends Biotechnol; 2013 Mar; 31(3):147-54. PubMed ID: 23178074
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Utilization of tyrosine- and histidine-containing dipeptides to enhance productivity and culture viability.
    Kang S; Mullen J; Miranda LP; Deshpande R
    Biotechnol Bioeng; 2012 Sep; 109(9):2286-94. PubMed ID: 22447498
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A new controversy in respiratory equipment management: reusables versus disposed disposables versus reused disposables.
    Walton JR
    Respir Care; 1986 Mar; 31(3):213-7. PubMed ID: 10315691
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.